Expert opinion on pharmacotherapy
-
Expert Opin Pharmacother · Aug 2016
Randomized Controlled TrialEvaluation of rotigotine transdermal patch for the treatment of depressive symptoms in patients with Parkinson's disease.
To evaluate the dopamine receptor agonist, rotigotine, for improving depressive symptoms in patients with Parkinson's disease (PD). ⋯ No statistically significant improvement in depressive symptoms were observed with rotigotine versus placebo. ADL, motor function, and patient-rated apathy improved numerically. ClinicalTrials.gov: NCT01523301.